Drug Type Small molecule drug |
Synonyms d-Chlorpheniramine maleate (JP17), Dexchlorpheniramine maleate (USP), Mylaramine + [4] |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (20 May 1964), |
Regulation- |
Molecular FormulaC20H23ClN2O4 |
InChIKeyDBAKFASWICGISY-DASCVMRKSA-N |
CAS Registry2438-32-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00668 | Dexchlorpheniramine Maleate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bites and Stings | JP | 20 May 1964 | |
Drug Eruptions | JP | 20 May 1964 | |
Eczema | JP | 20 May 1964 | |
Pruritus | JP | 20 May 1964 | |
Rhinitis, Allergic | JP | 20 May 1964 | |
Rhinitis, Vasomotor | JP | 20 May 1964 | |
Urticaria | JP | 20 May 1964 | |
Conjunctivitis, Allergic | US | - | - |
Conjunctivitis, Allergic | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sunburn | Phase 3 | BR | 11 Mar 2010 | |
Insect Bites and Stings | Phase 3 | BR | 14 Oct 2009 |